Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Cash from Operations (2023 - 2025)

Onconetix (ONCO) has disclosed Cash from Operations for 2 consecutive years, with 921831.0 as the latest value for Q4 2024.

  • On a quarterly basis, Cash from Operations rose 78.62% to 921831.0 in Q4 2024 year-over-year; TTM through Dec 2024 was 10500000.0, a 22.69% increase, with the full-year FY2024 number at 10500000.0, up 22.69% from a year prior.
  • Cash from Operations was 921831.0 for Q4 2024 at Onconetix, up from 1146578.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 921831.0 in Q4 2024 to a low of 5232063.0 in Q1 2024.